Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque to up to five ...
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (known as MSD outside the United States and Canada) (NYSE: MRK) today announced that NEXPLANON ® (etonogestrel implant) 68 mg, a long-acting, ...
Clinical data support a 5-year duration for the Nexplanon implant, with no reported pregnancies during the extended 2-year study period. The Food and Drug Administration (FDA) has extended the ...
If, like me, you keep seeing those "I armor up" commercials while binge-watching Broad City on Hulu, you might be curious about how Nexplanon works. Just how effective is Nexplanon, the birth control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results